Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
- 1 September 1999
- journal article
- guideline
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (9), 2971
- https://doi.org/10.1200/jco.1999.17.9.2971
Abstract
No abstract availableThis publication has 204 references indexed in Scilit:
- An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomitingEuropean Journal Of Cancer, 1997
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Oral Metoclopramide With or Without Diphenhydramine: Potential for Prevention of Late Nausea and Vomiting Induced by CisplatinJNCI Journal of the National Cancer Institute, 1988
- Effect of the cognitive hierarchy in the systematic desensitization treatment of anticipatory nausea in cancer patients: A component comparison with relaxation only, counseling, and no treatmentCognitive Therapy and Research, 1986
- Current Status of BenzodiazepinesNew England Journal of Medicine, 1983
- Antiemetic Efficacy of MetoclopramideNew England Journal of Medicine, 1982
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Methylprednisolone as an AntiemeticNew England Journal of Medicine, 1981
- Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1979